CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

VIR's Free Cash Flow Growth by Quarter and Year

Vir Biotechnology Inc 's Free Cash Flow results by quarter and year




VIR Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 35.13 7.70 -82.05 -38.89
III Quarter September 117.90 -105.81 -49.84 38.89
II Quarter June 960.14 140.06 -10.64 0.00
I Quarter March 550.09 -89.53 -48.41 0.00
FY   1,663.26 -47.58 -190.94 0.00



VIR Free Cash Flow forth quarter 2022 Y/Y Growth Comment
Vir Biotechnology Inc reported Free Cash Flow surge of 356.18% year on year in the forth quarter 2022, to $ 35.13 millions, this is lower than Vir Biotechnology Inc 's recent average Free Cash Flow surge of 471%.

Looking into forth quarter 2022 results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Free Cash Flow growth. While Vir Biotechnology Inc ' s Free Cash Flow doubling of 356.18% ranks overall at the positon no. 112 in the forth quarter 2022.




VIR Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December 356.18 % - - -
III Quarter September - - - -
II Quarter June 585.52 % - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Vir Biotechnology Inc 's forth quarter 2022 Free Cash Flow $ 35.13 millions VIR's Income Statement
Vir Biotechnology Inc 's forth quarter 2021 Free Cash Flow $ 7.70 millions Quarterly VIR's Income Statement
New: More VIR's historic Free Cash Flow Growth >>


VIR Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December -70.21 % - - -
III Quarter September -87.72 % - - -
II Quarter June 74.54 % - - -
I Quarter March 7044.03 % - - -
FY (Year on Year)   - - - -




Free Cash Flow forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #15
Overall #112

Free Cash Flow Y/Y Growth Statistics
High Average Low
585.53 % 471 % 356.48 %
(Jun 30 2022)   (Dec 31 2022)
Free Cash Flow forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #4
Healthcare Sector #15
Overall #112
Free Cash Flow Y/Y Growth Statistics
High Average Low
585.53 % 471 % 356.48 %
(Jun 30 2022)   (Dec 31 2022)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Vir Biotechnology Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
7048.65 % 1741.32 % -87.72 %
(Mar 31 2022)  


VIR's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2022 Vir Biotechnology Inc realized fall in Free Cash Flow from the previous quarter by -70.21% to $ 35.13 millions, from $ 117.90 millions achived in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 32 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Vir Biotechnology Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1540.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #33
Healthcare Sector #135
Overall #1540
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #33
Healthcare Sector #135
Overall #1540
Free Cash Flow Q/Q Growth Statistics
High Average Low
7048.65 % 1741.32 % -87.72 %
(Mar 31 2022)  


VIR's IV. Quarter Q/Q Free Cash Flow Comment
In the IV. Quarter 2022 Vir Biotechnology Inc disclosed fall in Free Cash Flow from the third quarter by -70.21% to $ 35.13 millions, from $ 117.90 millions achived in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 32 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Vir Biotechnology Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1540.


Vir Biotechnology Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 1,731.28 $ 1,704.32 $ 1,467.62 $ 629.02 $ -25.77
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) 1.58 % 16.13 % 133.32 % - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Vir Biotechnology Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 356.18% year on year, to $ 1,731 millions if the fiscal year would have ended in Dec 31 2022.
Vir Biotechnology Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Vir Biotechnology Inc realized the fastest Free Cash Flow growth, in Biotechnology & Pharmaceuticals industry.
But sequential growth rate was slower at 1.58 % from $1704.32 millions reported in twelve months ending a quarter before.
Still this was confirmation of convincing trend, as the typical sequential Free Cash Flow advancement lays at 0%. In the Dec 31 2022 period, Vir Biotechnology Inc had cumulative twelve months Free Cash Flow of $ 1,731 millions compare to free cash outflow of $ -26 millions a year ago.
Not only that Vir Biotechnology Inc has restored the profitability, it is already heading full steam with better then normal Free Cash Flow gain, from the twelve months ending in the quarter Sep 30 2022 of 1.58 % from $1704.32 millions.

Vir Biotechnology Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 14
S&P 500 # 205
Cumulative Free Cash Flow growth Comment
Vir Biotechnology Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 356.18% year on year, to $ 1,731 millions if the fiscal year would have ended in Dec 31 2022.
Vir Biotechnology Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 0% and higher than % growth in Sep 30 2022. And, Vir Biotechnology Inc realized the fastest Free Cash Flow growth, in Biotechnology & Pharmaceuticals industry.
But sequential increase was beneth at 1.58 % from $1704.32 millions recorded in the period from Sep 30 2022 to Dec 31 2021 Annabelle  Williams added on.
Yet it was confirmation of strength, as the typical Q/Q TTM gain stands at 0%.
The progress was much more impressive from the previous reporting period showed at 1.58 % jump from $1704.32 millions in twelve months ending a quarter Sep 30 2022. In the Dec 31 2022 period, Vir Biotechnology Inc had cumulative twelve months Free Cash Flow of $ 1,731 millions compare to free cash outflow of $ -26 millions a year ago.
Besides Biotechnology & Pharmaceuticals company has restored the prosperity, the company is already improving fast and showing better then normal Free Cash Flow gain, from the period from Sep 30 2022 to Dec 31 2021 of 1.58 % from $1704.32 millions.

Vir Biotechnology Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 14
S&P 500 # 205




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
VIR's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for VIR's Competitors
Free Cash Flow Growth for Vir Biotechnology Inc 's Suppliers
Free Cash Flow Growth for VIR's Customers

You may also want to know
VIR's Annual Growth Rates VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Dividend Payout Ratio
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Comparisons



Companies with similar Free Cash Flow fall for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2022
Perrigo Company Plc602.29%$ 602.292 millions
Assertio Holdings inc 546.26%$ 546.260 millions
Progyny Inc 484.42%$ 484.424 millions
Organon and Co 468.09%$ 468.085 millions
Eagle Pharmaceuticals inc 364.76%$ 364.757 millions
Vir Biotechnology Inc 356.48%$ 356.478 millions
Psychemedics Corp235.22%$ 235.221 millions
Carlisle Companies Incorporated199.20%$ 199.202 millions
Electromed Inc 190.21%$ 190.213 millions
Acorda Therapeutics Inc 179.81%$ 179.815 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ANTE's Profile

Stock Price

ANTE's Financials

Business Description

Fundamentals

Charts & Quotes

ANTE's News

Suppliers

ANTE's Competitors

Customers & Markets

Economic Indicators

ANTE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071